title: MRI for evaluation of treatment response in rectal cancer.
abstract: MRI plays an increasingly pivotal role in the clinical staging of rectal cancer in the baseline and post-treatment settings. An accurate evaluation of response to neoadjuvant treatment is crucial because of its major influence on patient management and quality of life. However, evaluation of treatment response is challenging for both imaging and clinical assessments owing to treatment-related inflammation and fibrosis. At one end of the spectrum are clinical yT4 rectal cancers, wherein precise post-treatment MRI evaluation of tumour spread is particularly important for avoiding unnecessary exenterative surgery. At the other extreme, for tumours with clinical near-complete response or clinical complete response to neoadjuvant treatment, less invasive treatment may be suitable instead of the standard surgical approach such as, for example, a "Watch and Wait" approach or perhaps local excision. Ideally, the goal of post-treatment MRI evaluation would be to identify these subgroups of patients so that they might be spared unnecessary surgical intervention. It is known that post-chemoradiation therapy restaging using conventional MR sequences is less accurate than baseline staging, particularly in confirming T0 disease, largely owing to the difficulty in distinguishing fibrosis, oedema and normal mucosa from small foci of residual tumour. However, there is a growing utilization of multiparametric MRI, which has superseded other types of evaluations and requires review and periodic re-evaluation. This commentary discusses the current status of multiparametric MRI in the post-treatment setting and the challenges facing imaging in general in the accurate determination of treatment response.
authors.affiliation: Radiology Department, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
authors.forename: Ivana M
authors.initials: IM
authors.lastname: Blazic
authors.affiliation: Radiology Department, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
authors.forename: Naomi M
authors.initials: NM
authors.lastname: Campbell
authors.affiliation: Radiology Department, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
authors.forename: Marc J
authors.initials: MJ
authors.lastname: Gollub
mesh_terms: D059248:Chemoradiotherapy; D006801:Humans; D008279:Magnetic Resonance Imaging; D020360:Neoadjuvant Therapy; D009367:Neoplasm Staging; D012004:Rectal Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology / Q000628:therapy*